About
Nalu Bio uses a proprietary AI-powered technology platform to develop novel therapeutics targeting the endocannabinoid system (ECS) for treating inflammatory, immune, and metabolic diseases.
Explore Nalu Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.